Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Morgenthaler
AddedFeb 13, 2024
UpdatedJun 28, 2026
Morgenthaler

Morgenthaler

Operating

Morgenthaler Ventures: A US-based private equity firm investing in healthcare, tech, and life sciences.

Location
Menlo Park, CA, US
Founded
1968
Firm
Compare
Portfolio
Employees

Morgenthaler Ventures operates as a venture capital firm. The Company invests in medical devices, health care services, pharmaceutical, biotechnology, consumer and enterprise software, mobile computing, and life sciences companies.

Morgenthaler Ventures serves customers in the United States.

Morgenthaler - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments141
Current Portfolio Count45
Total Portfolio Exits17

Top Investment Stages

Series B31 (23.8%)
Series Unknown30 (23.1%)
Series A26 (20.0%)
Series C25 (19.2%)
Series D18 (13.8%)

Stage Mix

Series B 24%Series Unknown 23%Series A 20%Series C 19%Series D 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Relievant Medsystems logo

Relievant Medsystems

Setpoint Medical logo

Setpoint Medical

Moximed logo

Moximed

Nuvaira logo

Nuvaira

Vapotherm logo

Vapotherm

Second Genome logo

Second Genome

Elcelyx Therapeutics logo

Elcelyx Therapeutics

Galleon Pharmaceuticals logo

Galleon Pharmaceuticals

Sunlight Aerospace logo

Sunlight Aerospace

Forsight Labs logo

Forsight Labs

Calithera Biosciences logo

Calithera Biosciences

Convo logo

Convo

Optiscan Biomedical logo

Optiscan Biomedical

R2 Semiconductor logo

R2 Semiconductor

Doximity logo

Doximity

Locbox logo

Locbox

Sohoos logo

Sohoos

Mosaic Biosciences logo

Mosaic Biosciences

LendingClub logo

LendingClub

Evernote logo

Evernote

Spine Wave logo

Spine Wave

FST Life Sciences logo

FST Life Sciences

Bluearc logo

Bluearc

Adastra Pharmaceuticals logo

Adastra Pharmaceuticals

Foundry logo

Foundry

Morgenthaler - Similar Investment Firms

Morgenthaler Partners logo

Morgenthaler Partners

mpepartners.com

Kleiner Perkins Caufield & Byers logo

Kleiner Perkins Caufield & Byers

kleinerperkins.com

Mayo Clinic Ventures logo

Mayo Clinic Ventures

Menlo Ventures logo

Menlo Ventures

menlovc.com

Merlin Ventures logo

Merlin Ventures

merlin.vc

McKesson Ventures logo

McKesson Ventures

Mohr Davidow Ventures logo

Mohr Davidow Ventures

mdv.com

Versant Ventures logo

Versant Ventures

MentorTech Ventures logo

MentorTech Ventures

Atlas Venture logo

Atlas Venture

atlasventure.com

Meritech Capital Partners logo

Meritech Capital Partners

Bioventures Investors logo

Bioventures Investors

Mithril Capital Management logo

Mithril Capital Management

mithril.com

Foresite Capital logo

Foresite Capital

Merlin Nexus logo

Merlin Nexus

Morgenthaler - Classification

Also Known As
  • Morgenthaler Llp
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end